N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease - The African American Study of Kidney Disease and Hypertension (AASK)

被引:37
|
作者
Astor, B. C. [1 ,2 ]
Yi, S. [1 ]
Hiremath, L. [3 ]
Corbin, T. [4 ]
Pogue, V. [5 ]
Wilkening, B. [6 ]
Peterson, G. [7 ]
Lewis, J. [8 ]
Lash, J. P. [9 ]
Van Lente, F. [10 ,11 ]
Gassman, J. [12 ]
Wang, X. [12 ]
Bakris, G. [13 ]
Appel, L. J. [1 ,2 ]
Contreras, G. [14 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Epidemiol, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA
[3] Ohio State Univ, Dept Nephrol, Columbus, OH 43210 USA
[4] Univ Michigan, Dept Med, Div Internal Med, Ann Arbor, MI 48109 USA
[5] Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, Dept Med, New York, NY 10032 USA
[6] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA
[7] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[8] Vanderbilt Univ, Div Nephrol, Nashville, TN USA
[9] Univ Illinois, Nephrol Sect, Chicago, IL USA
[10] Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA
[11] Cleveland Clin Fdn, Dept Hypertens & Nephrol, Cleveland, OH 44195 USA
[12] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA
[13] Univ Chicago, Pritzker Sch Med, Dept Med, Chicago, IL 60637 USA
[14] Univ Miami, Miller Sch Med, Dept Med, Div Nephrol & Hypertens, Miami, FL 33152 USA
关键词
cardiovascular diseases; heart failure; hypertension; renal; kidney; natriuretic peptides;
D O I
10.1161/CIRCULATIONAHA.107.724187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Higher levels of N-terminal prohormone brain-type natriuretic peptide (NT-proBNP) predict cardiovascular disease (CVD) in several disease states, but few data are available in patients with chronic kidney disease or in blacks. Methods and Results - The African American Study of Kidney Disease and Hypertension trial enrolled hypertensive blacks with a glomerular filtration rate of 20 to 65 mL . min(-1) . 1.73 m(-2) and no other identified cause of kidney disease. NT-proBNP was measured with a sandwich chemiluminescence immunoassay (coefficient of variation 2.9%) in 994 African American Study of Kidney Disease and Hypertension participants. NT-proBNP was categorized as undetectable, low, moderate, or high. Proteinuria was defined as 24-hour urinary protein - creatinine ratio >0.22. A total of 134 first CVD events (CVD death or hospitalization for coronary artery disease, heart failure, or stroke) occurred over a median of 4.3 years. Participants with high NT-proBNP were much more likely to have a CVD event than participants with undetectable NT-proBNP after adjustment (relative hazard 4.0 [95% confidence interval [CI] 2.1 to 7.6]). A doubling of NT-proBNP was associated with a relative hazard of 1.3 (95% CI 1.0 to 1.6) for coronary artery disease, 1.7 (95% CI 1.4 to 2.2) for heart failure, 1.1 (95% CI 0.9 to 1.4) for stroke, and 1.8 (95% CI 1.4 to 2.4) for CVD death. The association of NT-proBNP with CVD events was significantly stronger (P-interaction = 0.05) in participants with than in those without proteinuria. Higher NT-proBNP was not associated with renal disease progression. Conclusions - These results suggest that elevated NT-proBNP levels are associated with higher CVD risk among blacks with hypertensive kidney disease. This association may be stronger in individuals with significant proteinuria.
引用
收藏
页码:1685 / 1692
页数:8
相关论文
共 50 条
  • [1] Correlates of N-Terminal Prohormone Brain Natriuretic Peptides in African Americans with Hypertensive Chronic Kidney Disease: The African American Study of Kidney Disease and Hypertension
    Yi, S.
    Contreras, G.
    Miller, E. R.
    Appel, L. J.
    Astor, B. C.
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (04) : 292 - 298
  • [2] Cardiovascular outcomes in the African American study of Kidney Disease and Hypertension (AASK) trial
    Norris, Keith
    Bourgoigne, Jacque
    Gassman, Jennifer
    Hebert, Lee
    Middleton, John
    Phillips, Robert A.
    Randall, Otelio
    Rostand, Stephen
    Sherer, Susan
    Toto, Robert D.
    Wright, Jackson T., Jr.
    Wang, Xuelei
    Greene, Tom
    Appel, Lawrence J.
    Lewis, Julia
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (05) : 739 - 751
  • [3] N-terminal of the prohormone brain natriuretic peptide is a predictor of hemodynamic instability in valve disease
    Duchnowski, Piotr
    Hryniewiecki, Tomasz
    Kusmierczyk, Mariusz
    Szymanski, Piotr
    BIOMARKERS IN MEDICINE, 2019, 13 (05) : 353 - 358
  • [4] Cardiovascular outcomes in the African American (AA) study of hypertension and kidney disease (AASK).
    Norris, K
    Bourgoignie, J
    Gassman, J
    Hebert, L
    Middleton, J
    Phillips, R
    Randall, O
    Rostand, S
    Sherer, S
    Toto, R
    Wright, J
    Wang, XL
    Kopple, J
    Lewis, J
    Greene, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 673A - 673A
  • [5] The African-American Study of Kidney disease and hypertension (AASK)
    Douglas, JG
    CIRCULATION, 2002, 105 (05) : E39 - E39
  • [6] N-TERMINAL PROHORMONE B-TYPE NATRIURETIC PEPTIDE IN CHILDREN WITH CHRONIC KIDNEY DISEASE
    Okarska-Napierala, Magdalena
    Ziolkowska, Helena
    Pietrzak, Radoslaw
    Skrzypczyk, Piotr
    Jankowska, Katarzyna
    Werner, Bozena
    Roszkowska-Blaim, Maria
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 162 - 162
  • [7] Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK)
    Chen, Teresa K.
    Estrella, Michelle M.
    Astor, Brad C.
    Greene, Tom
    Wang, Xuelei
    Grams, Morgan E.
    Appel, Lawrence J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (08) : 1329 - 1335
  • [8] Value of the N-terminal of prohormone brain natriuretic peptide in diagnosis of Kawasaki disease
    Ye, Qing
    Shao, Wen-xia
    Shang, Shi-qiang
    Zhou, Ming-ming
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 178 : 5 - 7
  • [9] The African American Study of Kidney Disease and Hypertension (AASK) Pilot Study - Overview
    Kusek, JW
    Agodoa, LY
    Glassock, R
    Wright, JT
    Kirk, KA
    Lee, JY
    CONTROLLED CLINICAL TRIALS, 1996, 17 (04): : S1 - +
  • [10] Subject compliance and retention in the African American Study of Kidney Disease and Hypertension (AASK)
    Brooks, D. H.
    Charleston, J.
    Dowie, D.
    Hall, Y.
    Gabriel, A.
    Hiremath, L.
    Lightfoot, T.
    Sika, M.
    Smith, W.
    Wang, X.
    ETHNICITY & DISEASE, 2006, 16 (03) : S37 - S37